Stock market wrap: top gainers and losers on November 17, 2026
SELLAS Life Sciences (SLS) appeared as a top gainer on Tuesday, having filed an 8-K on 2026-11-17 announcing positive pivotal Phase 3 REGAL trial data for its immunotherapeutic cancer vaccine, Galinpepimut-S (GPS). The stock's technical…
SELLAS Life Sciences (SLS) appeared as a top gainer on Tuesday, having filed an 8-K on 2026-11-17 announcing positive pivotal Phase 3 REGAL trial data for its immunotherapeutic cancer vaccine, Galinpepimut-S (GPS)¹. The stock's technical setup showed 100.0 confidence across the Minervini Trend Template, Pocket Pivot, and 52-Week High Breakout².
Other top gainers included GP, which showed a 50.0 confidence Pocket Pivot³, and GLSI, which reported the acceptance of abstracts at SABCS 2026 and showed an 85.3 confidence Gap and Go⁴. AYTU also ranked among the top gainers after reporting a Q1 loss but beating revenue estimates⁵.
On the opposite side of the session, STEM was among the top losers after reporting a Q3 loss and missing revenue estimates. Other top losers included CUE, PSIG, RCAT, and GMM.
Activity remained concentrated in mega-cap tech, with NVDA, MU, AMD, MSFT, and AAPL as the most active tickers. In the broader macro environment, none of the six tracked signals were risk-off.
Looking ahead, several highly traded companies are due around their estimated earnings dates: PANW and TJX around 2026-11-18, WMT around 2026-11-19, and DELL, ADI, and BABA around 2026-11-24.
Educational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.